Public Charity

STAAR LOW-GRADE SEROUS OVARIAN CANCER

STAAR LOW-GRADE SEROUS OVARIAN CANCER is a Public Charity headquartered in CHICAGO, IL. Financial data from the 2024 filing: $300K revenue, $56K expenses, $464K total assets. 6 publicly reported grants to this organization, totaling roughly $88K, appear in IRS filings.

EIN: 844672869 CHICAGO, IL Latest filing: 2024
Total Revenue$300K
Total Expenses$56K
Total Assets$464K
Grant Records6
Funding Total$88K
Filing Years2020–2024

Mission

STAAR EXISTS TO ADVOCATE FOR AND RAISE FUNDS FOR RESEARCH SPECIFICALLY ON THE LOW-GRADE SEROUS CARCINOMA SUB-TYPE OF OVARIAN CANCER IN THE UNTED STATES. THROUGHOUT THE YEAR, WE DROVE AWARENESS OF THE SYMPTOMS OF OVARIAN CANCER AND THE UNDER-FUNDING OF RESEARCH FOR THE LGSC SUB-TYPE. WE MAKE CONNECTIONS WITH RESEARCHERS AND ULTIMATELY HAVE MADE THREE GRANTS, SOOME WITH FUNDS RAISED IN 2021.

Officers & Directors

V-CHAIR FUND Alyssa Toomes
DIRECTOR Bailey Wolfe
TREASURER Christina Campbell
DIRECTOR Connie Bell
DIRECTOR Ellie Habib
DIRECTOR Emma Schlamm

Officer compensation and complete director data available with membership.

Top Grant Purposes

GENERAL SUPPORT
$38,959 1 grant
HEALTH SERVICES
$15,000 1 grant
HEALTH
$12,666 1 grant
COMMUNITY BENEFIT
$10,000 1 grant
CHARITABLE DONATION
$6,100 1 grant

Financial Trends

Year Revenue Expenses Assets
2024 $300K $56K $464K
2023 $400K $277K $448K
2022 $311K $514K $164K
2021 $168K $33K $230K
2020 $97K $2K $94K

Between 2020 and 2024, reported annual revenue grew from $97K to $300K (+210%), with total assets most recently reported at $464K.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for STAAR LOW-GRADE SEROUS OVARIAN CANCER

Complete financials, all 6 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 498,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
7-day free trial Cancel any time